NICC | SoC | |
---|---|---|
Cardiovascular diseases | ||
Atrial fibrillation | 210 (44.0) | 230 (47.9) |
EHRA Stadium I | 12 (5.7) | 11 (4.8) |
II | 169 (79.6) | 192 (83.5) |
III | 24 (11.4) | 21 (9.1) |
IV | 0 (0.0) | 2 (0.9) |
ESC class paroxysmal atrial fibrillation | 103 (49.0) | 125 (54.3) |
ESC class persistent atrial fibrillation | 46 (21.9) | 55 (23.9) |
ESC class long-lasting persistent atrial fibrillation | 5 (2.4) | 2 (0.9) |
Previous hospitalisation due to atrial fibrillation | 119 (56.7) | 127 (55.2) |
Angina pectoris | 34 (7.1) | 31 (6.5) |
CCS Grade I | 7 (20.6) | 3 (9.7) |
II | 16 (47.1) | 23 (74.2) |
III | 7 (20.6) | 2 (6.5) |
Unknown | 4 (11.8) | 3 (9.7) |
Hypertension | 341 (71.5) | 342 (71.2) |
Previous hospitalisation due to hypertension | 56 (16.5) | 68 (19.9) |
Heart failure | 213 (44.7) | 210 (43.8) |
NYHA stadium I | 8 (3.8) | 5 (2.4) |
II | 145 (68.1) | 137 (65.2) |
III | 56 (26.3) | 67 (31.9) |
IV | 3 (1.4) | 1 (0.5) |
Unknown | 1 (0.5) | 0 (0.0) |
AHA stadium A | 3 (1.4) | 3 (1.4) |
B | 126 (59.2) | 113 (53.8) |
C | 72 (33.8) | 78 (37.1) |
D | 3 (1.4) | 1 (0.5) |
Unknown | 9 (4.2) | 15 (7.1) |
Previous hospitalisation due to heart failure | 111 (52.4) | 116 (55.2) |
Medical history | ||
Coronary artery disease | 239 (50.1) | 244 (50.8) |
Previous myocardial infarction | 103 (21.6) | 118 (24.6) |
Modified CHA2DS2-VASc score | 3.8 (1.7) | 3.7 (1.6) |
Primary heart valve disease | 54 (11.3) | 61 (12.7) |
Cardiomyopathy | 25 (5.2) | 34 (7.1) |
Cardiac decompensation | 42 (8.8) | 59 (12.3) |
Coronary revascularization | 164 (34.6) | 162 (33.8) |
Bypass surgery | 60 (12.6) | 71 (14.8) |
Heart valve surgery | 48 (10.1) | 43 (9.0) |
Catheter ablation | 42 (8.8) | 48 (10.0) |
Pacemaker | 50 (10.5) | 50 (10.4) |
Defibrillator | 27 (5.7) | 35 (7.3) |
Peripheral artery disease | 35 (7.3) | 47 (9.8) |
Cardiovascular risk factors | ||
1st degree relative with myocardial infarction < 50 years | 57 (11.9) | 49 (10.2) |